EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Total Synthesis of Core 3 & Core 4‐Type Mucin Glycan Derivatives

Carmen R. Cori, Rachel Hevey

Helvetica Chimica Acta · 2024-07 · 107 (7)

DOI: 10.1002/hlca.202400026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Helvetica Chimica Acta, online erschienen am 03.05.2024. Verfasst von Carmen R. Cori und 1 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innosuisse - Schweizerische Agentur für Innovationsförderung, Universität Basel.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent studies have demonstrated the ability of mucin O‐glycans to attenuate virulence in diverse, cross‐kingdom pathogens, sparking interest in their development as a novel therapeutic approach against infection. Although their virulence attenuating activity is evident, mucin glycans obtained from native sources comprise mixtures of several hundred distinct structures, and therefore the specific active glycan epitopes and molecular mechanisms of virulence attenuation remain unclear. Individual mucin glycan structures cannot be purified from native sources and are not amenable to automated synthesis; therefore, to further investigate the phenomena of virulence attenuation we have been developing convergent and scalable methods (>30 mg per target glycan) to assemble a mucin O‐glycan library in sufficient scale and purity to facilitate biological studies. Previously we described a method to obtain core 1 & core 2‐type mucin glycan derivatives that have since been used to identify active epitopes in Candida albicans and Vibrio cholerae . In the current study, we describe the expansion of our glycan library to include core 3 & core 4‐type derivatives, increasing the structural diversity of our platform for biological evaluation.

Förderung

  • Innosuisse - Schweizerische Agentur für Innovationsförderung
  • Universität Basel

Zitieren

APA

Cori, C. R., & Hevey, R. (2024). Total Synthesis of Core 3 & Core 4‐Type Mucin Glycan Derivatives. Helvetica Chimica Acta, 107(7). https://doi.org/10.1002/hlca.202400026

Vancouver

Cori CR, Hevey R. Total Synthesis of Core 3 & Core 4‐Type Mucin Glycan Derivatives. Helvetica Chimica Acta. 2024;107(7). doi:10.1002/hlca.202400026

BibTeX
@article{Cori2024,
  author = {Cori, Carmen R. and Hevey, Rachel},
  title = {Total Synthesis of Core 3 & Core 4‐Type Mucin Glycan Derivatives},
  journal = {Helvetica Chimica Acta},
  year = {2024},
  volume = {107},
  number = {7},
  doi = {10.1002/hlca.202400026}
}
Kostenlos starten →